HAO
Income statement / Annual
Last year (2022), Haoxi Health Technology Limited's total revenue was $28.23 M,
an increase of 74.72% from the previous year.
In 2022, Haoxi Health Technology Limited's net income was $969,752.00.
See Haoxi Health Technology Limited’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2022
|
FY-2021
|
FY-2020
|
Period Ended |
06/30/2023 |
06/30/2022 |
06/30/2021 |
Operating Revenue |
$28.23 M
|
$16.16 M
|
$12.85 M
|
Cost of Revenue |
$26.17 M |
$15.51 M |
$12.24 M |
Gross Profit |
$2.06 M |
$648,721.00 |
$605,577.00 |
Gross Profit Ratio |
0.07 |
0.04 |
0.05 |
Research and Development
Expenses |
$58,161.00
|
$102,524.00
|
$62,645.00
|
General & Administrative
Expenses |
$775,961.00
|
$239,941.00
|
$169,719.00
|
Selling & Marketing
Expenses |
$32,133.00
|
$37,488.00
|
$42,659.00
|
Selling, General &
Administrative Expenses |
$808,094.00
|
$277,429.00
|
$212,378.00
|
Other Expenses |
$15,496.00 |
$788.00 |
$0.00 |
Operating Expenses |
$866,255.00 |
$379,953.00 |
$275,023.00 |
Cost And Expenses |
$27.03 M |
$15.89 M |
$12.52 M |
Interest Income |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$20,902.00 |
$9,961.00 |
$5,270.00 |
Depreciation &
Amortization |
$8,393.00
|
$2,212.00
|
$411.00
|
EBITDA |
$1.20 M
|
$270,980.00
|
$330,960.00
|
EBITDA Ratio |
0.04 |
0.02 |
0.03 |
Operating Income Ratio
|
0.04
|
0.02
|
0.03
|
Total Other
Income/Expenses Net |
-$5,405.00
|
-$9,175.00
|
-$5,266.00
|
Income Before Tax |
$1.19 M |
$259,595.00 |
$325,284.00 |
Income Before Tax Ratio
|
0.04
|
0.02
|
0.03
|
Income Tax Expense |
$220,653.00 |
$15,008.00 |
$21,219.00 |
Net Income |
$969,752.00 |
$244,587.00 |
$304,065.00 |
Net Income Ratio |
0.03 |
0.02 |
0.02 |
EPS |
0.0304 |
0.0077 |
0.0095 |
EPS Diluted |
0.0304 |
0.0077 |
0.0095 |
Weighted Average Shares
Out |
$31.88 M
|
$31.88 M
|
$31.88 M
|
Weighted Average Shares
Out Diluted |
$31.88 M
|
$31.88 M
|
$31.88 M
|
Link |
|
|
|